Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tenaya Therapeutics, Inc. (TNYA) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tenaya Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1858848.
Total stock buying since 2021: $240,414,488.
Total stock sales since 2021: $462,900.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 71,428,568 | $49,999,996 | 49,685 | $42,134 | 0 | $0 |
| 2024 | 0 | $0 | 61,006 | $301,588 | 0 | $0 |
| 2023 | 3,013,558 | $7,835,196 | 26,828 | $105,473 | 0 | $0 |
| 2022 | 60,415,115 | $157,079,296 | 1,353 | $13,705 | 0 | $0 |
| 2021 | 1,700,000 | $25,500,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 22,548 | $28,251 | 0 | $0 |
| 2025-05 | 0 | $0 | 7,516 | $3,328 | 0 | $0 |
| 2025-03 | 71,428,568 | $49,999,996 | 19,621 | $10,555 | 0 | $0 |
| 2024-11 | 0 | $0 | 2,258 | $4,786 | 0 | $0 |
| 2024-08 | 0 | $0 | 19,539 | $56,562 | 0 | $0 |
| 2024-03 | 0 | $0 | 9,900 | $69,300 | 0 | $0 |
| 2024-02 | 0 | $0 | 29,309 | $170,940 | 0 | $0 |
| 2023-08 | 0 | $0 | 26,828 | $105,473 | 0 | $0 |
| 2023-03 | 13,558 | $35,196 | 0 | $0 | 0 | $0 |
| 2023-02 | 3,000,000 | $7,800,000 | 0 | $0 | 0 | $0 |
| 2022-11 | 60,415,115 | $157,079,296 | 0 | $0 | 0 | $0 |
| 2022-04 | 0 | $0 | 1,353 | $13,705 | 0 | $0 |
| 2021-08 | 1,700,000 | $25,500,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-18 | Higa Tomohiro (SVP, Finance) | Sale | 2,962 | 1.25 | 3,711 |
| 2025-08-18 | Tingley Whittemore (Chief Medical Officer) | Sale | 5,053 | 1.25 | 6,331 |
| 2025-08-18 | Ali Faraz (Chief Executive Officer) | Sale | 14,533 | 1.25 | 18,209 |
| 2025-05-16 | Higa Tomohiro (SVP, Finance) | Sale | 1,390 | .44 | 615 |
| 2025-05-16 | Tingley Whittemore (Chief Medical Officer) | Sale | 2,937 | .44 | 1,301 |
| 2025-05-16 | Ali Faraz (Chief Executive Officer) | Sale | 3,189 | .44 | 1,412 |
| 2025-03-10 | Higa Tomohiro (SVP, Finance) | Sale | 2,482 | .54 | 1,335 |
| 2025-03-10 | Tingley Whittemore (Chief Medical Officer) | Sale | 7,398 | .54 | 3,980 |
| 2025-03-10 | Ali Faraz (Chief Executive Officer) | Sale | 9,741 | .54 | 5,240 |
| 2025-03-05 | Tcg Opportunity Iii Gp, Llc | Buy | 35,714,284 | .70 | 24,999,998 |
| 2025-03-05 | Goeddel David V | Buy | 35,714,284 | .70 | 24,999,998 |
| 2024-11-18 | Saito Chihiro (SVP, Accounting and Fin. Ops.) | Sale | 2,258 | 2.12 | 4,786 |
| 2024-08-16 | Saito Chihiro (SVP, Accounting and Fin. Ops.) | Sale | 2,363 | 2.89 | 6,838 |
| 2024-08-16 | Tingley Whittemore (Chief Medical Officer) | Sale | 7,428 | 2.90 | 21,504 |
| 2024-08-16 | Ali Faraz (Chief Executive Officer) | Sale | 9,748 | 2.90 | 28,220 |
| 2024-03-05 | Hoey Timothy (Chief Scientific Officer) | Sale | 6,600 | 7.00 | 46,200 |
| 2024-02-20 | Hoey Timothy (Chief Scientific Officer) | Sale | 6,569 | 5.74 | 37,686 |
| 2024-02-16 | Tingley Whittemore (Chief Medical Officer) | Sale | 6,500 | 5.86 | 38,090 |
| 2024-02-16 | Ali Faraz (Chief Executive Officer) | Sale | 6,358 | 5.86 | 37,257 |
| 2024-02-16 | Hoey Timothy (Chief Scientific Officer) | Sale | 4,681 | 5.86 | 27,430 |
| 2024-02-16 | Patterson Leone D (Chief Fin. and Bus. Officer) | Sale | 5,201 | 5.86 | 30,477 |
| 2023-08-29 | Hoey Timothy (Chief Scientific Officer) | Sale | 7,243 | 4.26 | 30,855 |
| 2023-08-16 | Tingley Whittemore (Chief Medical Officer) | Sale | 5,563 | 3.81 | 21,195 |
| 2023-08-16 | Ali Faraz (Chief Executive Officer) | Sale | 5,563 | 3.81 | 21,195 |
| 2023-08-16 | Hoey Timothy (Chief Scientific Officer) | Sale | 4,007 | 3.81 | 15,266 |
| 2023-08-16 | Patterson Leone D (Chief Fin. and Bus. Officer) | Sale | 4,452 | 3.81 | 16,962 |
| 2023-03-10 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 6,779 | 2.60 | 17,598 |
| 2023-03-10 | Goeddel David V (Director) | Buy | 6,779 | 2.60 | 17,598 |
| 2023-02-08 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 1,500,000 | 2.60 | 3,900,000 |
| 2023-02-08 | Goeddel David V (Director) | Buy | 1,500,000 | 2.60 | 3,900,000 |
| 2022-11-21 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 19,230,768 | 2.60 | 49,999,996 |
| 2022-11-21 | Srivastava Deepak (Director) | Buy | 230,769 | 2.60 | 599,999 |
| 2022-11-21 | Goeddel David V (Director) | Buy | 19,230,768 | 2.60 | 49,999,996 |
| 2022-11-17 | Casdin Capital, Llc | Buy | 2,492,042 | 2.60 | 6,479,309 |
| 2022-04-26 | Hoey Timothy (Chief Scientific Officer) | Sale | 1,353 | 10.13 | 13,705 |
| 2021-08-03 | Casdin Private Growth Equity Fund Gp, Llc (10% Owner) | Buy | 850,000 | 15.00 | 12,750,000 |
| 2021-08-03 | Casdin Eli (Director) | Buy | 850,000 | 15.00 | 12,750,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of TNYA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tenaya Therapeutics, Inc. (symbol TNYA, CIK number 1858848) see the Securities and Exchange Commission (SEC) website.